hims hers - Search News

Hims & Hers to offer at-home blood draws and lab testing

Hosted on MSN · 21h

Hims & Hers to offer at-home blood draws, lean into 'peptide innovations' with new acquisitions

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

Investopedia on MSN · 2d

Hims & Hers Stock Hits Record High on Blood-Testing Lab Acquisition

Key Takeaways Shares of Hims & Hers Health touched a fresh record high in Wednesday trading after the company announced its latest acquisition.The company said it acquired Trybe Labs, which will help Hims launch an at-home blood drawing and lab testing service.

GlobalData on MSN · 1d

Hims & Hers to introduce at-home lab testing with Trybe Labs acquisition

Hims & Hers, a health and wellness platform, is set to introduce at-home lab testing capabilities through the acquisition of US-based Trybe Labs. This strategic move is set to enhance the company's ability to offer whole body testing and personalised healthcare solutions directly to customers.

Hims & Hers Stock Plummets. Wegovy Shortage Is Over.

Barron's on MSN · 16h

Hims & Hers Stock Plummets. The Wegovy Shortage Is Over.

The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.

Investopedia on MSN · 17h

Hims & Hers Stock Drops as FDA Says Ozempic and Wegovy No Longer in Short Supply

Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in Eli Lilly’s Wegovy and Novo Nordisk’s Ozempic has been resolved.

The Motley Fool on MSN · 1d

Why Hims & Hers Stock Dropped Today

Raising its price target on the shares to $21, reports The Fly, BofA nonetheless reiterated an "underperform" ( i.e., sell) rating on Hims & Hers stock. Investors are taking the hint, and doing just that.

1d

Hims & Hers Health (HIMS) Upward Trajectory Boosted by Recent Acquisition

Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...

7h

Hims & Hers Health (HIMS) Projected to Post Quarterly Earnings on Monday

Hims & Hers Health (NYSE:HIMS – Get Free Report) is projected to announce its earnings results after the market closes on ...

SchaeffersResearch.com20h

Hims and Hers Stock Drops Weight as Earnings Loom

Healthcare stock Hims and Hers (HIMS) is sharply lower today but has contrarian potential next week ahead of earnings ...

1d

Hims & Hers Health: The Ultimate Pick For The Next Decade

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

3h

State of New Jersey Common Pension Fund D Reduces Holdings in Hims & Hers Health, Inc. (NYSE:HIMS)

State of New Jersey Common Pension Fund D decreased its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free ...

14hon MSN

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More

UnitedHealth declines following a report that the Justice Department has been investigating the company’s Medicare billing ...

22h

Hims & Hers: A Glorious Opportunity To Trim (Rating Downgrade)

Hims & Hers Health, Inc. stock surged 1,000% with strategic growth, but high valuation & short interest suggest taking ...

Money Morning1d

Ozempic Maker Is Ready to Fight Back Against Hims & Hers

Shares of Hims & Hers Health (HIMS) are getting crushed today after the Food & Drug Administration determined there is no ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results